Mode
Text Size
Log in / Sign up
N/A N=20 Treatment

Hybrid Cochlear Implants in Severe to Profound Adults, Children, and Adolescents

Hearing Loss, High-Frequency

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jun 2022
Primary outcome: Primary: Change in CNC Word Perception — 27.6; 34; 55.9; 68 percentage of words correct

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cochlear® Nucleus™ Hybrid L24 (Device); Cochlear® Nucleus™ Hybrid S12 (Device)
Age
Pediatric, Adult, Older Adult · 5+ yrs
Sex
All
Sponsor
Bruce J Gantz
Primary completion
Sep 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in CNC Word Perception
27.6; 34; 55.9; 68; 63.5; 64
SECONDARY
Change in Localization
23; 18; 34; 26; 32; 24
SECONDARY
AzBio +5 Noise
14.6; 26.4; 36.3; 46.5; 51.4

Summary

The purpose of this study is to determine if adults and children with residual low-pitch hearing in the severe hearing loss range can develop improved speech perception by combining their residual acoustic hearing with electrical stimulation through a short cochlear implant. The low-pitches would be amplified with a hearing aid and the high-pitch sounds would be stimulated electrically.

Eligibility Criteria

Inclusion Criteria

1.1 Criteria for Inclusion in Population 1

Criterion for selection will be subject interest in preservation of residual hearing; severe sensorineural hearing loss; lack of benefit from appropriately fit binaural hearing aids worn on a full-time basis; and realistic expectations. Qualified participants must also meet the following criteria for inclusion:

  • Eighteen year of age or older at the time of implantation.
  • Severe sensorineural hearing loss with a pure-tone average (PTA) between 60-90 dB HL between 125-1500 Hz and profound loss at higher frequencies in the ear to be implanted.
  • Speech Perception:
  • The Consonant-Nucleus-Consonant (CNC) word recognition score between 0% and 35% inclusive in the ear to be implanted.
  • The CNC word recognition score in the contralateral ear equal to or better than, in the ear to be implanted but not more than 60% in the best-aided condition.
  • English spoken as a primary language.
  • Willingness to comply with all study requirements.
  • Minimum of 30 day hearing aid trial with appropriately fit hearing aids worn on a full-time basis (8 hours per day).
  • Patent cochlea and normal cochlear anatomy.

1.2 Criteria for Inclusion in Population 2

Criterion for selection will be parent interest in preservation of residual hearing; severe post-lingual onset of sensorineural hearing loss; lack of benefit from appropriately fit binaural hearing aids worn on a full-time basis; and supportive family dynamics. Qualified participants must also meet the following criteria for inclusion:

  • Five to fifteen years of age at the time of implantation.
  • Severe sensorineural hearing loss with a pure-tone average (PTA) between 60-90 dB HL between 125-1500 Hz and profound loss at higher frequencies in the ear to be implanted.
  • Speech Perception:
  • The Phonetically Balanced-Kindergarten (PB-K) word recognition score between 0% and 50% inclusive in the ear to be implanted.
  • The PB-K word recognition score in the contralateral ear equal to or better than, in the ear to be implanted but not more than 60%.
  • English spoken as a primary language.
  • Willingness to comply with all study requirements.
  • Minimum of 30-day hearing aid trial with appropriately fit hearing aids worn on a full-time basis (8 hours per day)..
  • Patent cochlea and normal cochlear anatomy.
  • Must be in a habilitation/educational program with an emphasis on spoken language development.

Exclusion Criteria

1.3 Criteria for Exclusion in Populations 1 and 2

  • Medical or psychological conditions that contraindicate undergoing surgery.
  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array.
  • Unrealistic expectations on the part of the candidate and/or candidate's family, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices.
  • Unwillingness or inability of the candidate to comply with all investigational requirements.
  • Active middle ear infection.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01975571). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search